With much uncertainty in the supply chain, having the manufacturing capacity is a big concern for drug makers as they race to find treatments against the novel COVID-19 pandemic.
Univercells, a Belgian manufacturing specialist believes prefabricated vaccine facilities could help to scale up production fast.
The company partnered with a German construction firm Excyte to produce prefabricated facilities that enable rapid mass production in a shorter time frame.
The partnership will provide COVID-19 vaccine makers with ready-made facilities that will help in cutting down manufacturing costs of building its manufacturing sites to produce the vaccine.
Many companies that are developing treatments against COVID-19 said that limited manufacturing capacity is the biggest problem for most of them.
Many drug makers across the board are aiming to boost their manufacturing capacity to help alleviate some of that expected production bottleneck.